Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoonha Choi

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Nature|March 14, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|August 20, 2024
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2020
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial PneumoniaLuca Richeldi, Mary Beth Scholand, David A Lynch, et al.
The Lancet. Respiratory Medicine|April 6, 2019
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyGanesh Raghu, Kevin R Flaherty, David J Lederer, et al.
Nature Medicine|December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I StudyAdrian G Sacher, Wilson H Miller, Manish R Patel, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Nature|March 14, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|August 20, 2024
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2020
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial PneumoniaLuca Richeldi, Mary Beth Scholand, David A Lynch, et al.
The Lancet. Respiratory Medicine|April 6, 2019
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyGanesh Raghu, Kevin R Flaherty, David J Lederer, et al.
Nature Medicine|December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I StudyAdrian G Sacher, Wilson H Miller, Manish R Patel, et al.
Pageof 4